Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovarian Syndrome is common in overweight urban college girls and may increase the risk of heart and metabolic problems.

Acne can be managed with various treatments and requires psychological support due to its emotional impact.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Hair loss increases with age; alcohol raises risk, more female partners lowers it.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Women with PCOS can lead healthy lives with proper diagnosis and treatment.

PCOS is common, affects fertility, and requires personalized treatment to manage symptoms and health risks.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Finasteride effectively treats baldness but may cause sexual side effects.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.